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ABSTRACT: Improving the spatial alignment of emitting molecules has long been a goal of 
organic- light-emitting-diode development to improve device efficiencies and to generate 
polarized emission. Herein we describe a simple approach employing Sonogashira coupling 
with alkyne iridium(phenylpyridine)2(acetylacetone) synthons (2-5) to generate eight linear 
iridium complexes (6-13) with crystallographically determined lengths of up to 5 nm. By 
embedding these ‘long’ complexes into a polymer matrix and stretching it an improvement of 
polarization ratio of an unstretched and stretched film up to 7.1 times was achieved. 
Additionally, through the inclusion of ‘twists’ in the complexes the electronic coupling 
between the iridium center and substituent was controlled giving a system where the emission 
behavior is independent of the length. 
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INTRODUCTION 
The incorporation of phosphorescent emitters into OLEDs has been one of the most 
significant developments in the area of display technology due to the potential to harvest both 
singlet and triplet excitons, giving them a theoretical maximum internal quantum efficiency 
of 100 %.1 However, in practice the external quantum efficiencies often fall short of this. One 
of the causes for this is the orientation of the emitter: in a typical solution processed OLED 
the molecules are randomly orientated, this results in photons trapped in the film structure, 
lost to surface plasmons and wave guide modes, ultimately reduces the external quantum 
efficiency (EQE) of the device. A possible solution to this is to align the emitting molecules, 
controlling the direction and orientation of the photons being emitted i.e. polarizing the 
emission.2-8 This would not only improve the EQE but also generate plane polarized light 
allowing for a greater range of applications such as 3D projection, holography, and adaptive 
phase and amplitude modulation SLM. In order to align the emissions transition dipoles the 
emitting molecule needs to have: i) a single transition dipole moment in a single specific 
direction, iridium complexes, specifically Ir(2-phenylpyridine)2(L∩L) (where L∩L can be a 
range of ancillary ligands) have a strong transition dipole moment parallel to the Nppy-Ir-Nppy 
axis;2 and ii) the molecule must have a preferred orientation with respect to the substrate. 
Orientating the molecules with respect to the substrate can be achieved in a number of ways, 
by deposition as Langmuir-Blodgett films, rubbing or shearing, mechanical stretching, 
prealigned substrates, epitaxial vapor deposition, and fractional transfer on aligned 
substituents. Recently, Thompson, Moon and Mayr have demonstrated that it is possible to 
horizontally align emissive complexes (Ir(2-phenylpyridine)2(acetylactetone) or Ir(2-
phenylpyridine)3, etc.) through the choice of host molecules (N,N’-dicarbazolyl-4,4’biphenyl 
[CBP] or bis-4,6-(3,5-di-3-pyridylphenyl)-2-methylpyrimidine [B3PYMPM]) to achieve 
horizontal:vertical ratios as high as 75:25, this was attributed both to the high aspect ratio of 
the CBP and B3PYMPM and a proposed supramolecular interaction between the host 
molecule and the iridium complexes due to π-π interactions which effectively increased the 
aspect ratio of the complex.3, 7-10 The iridium complexes used in these studies have aspect 
ratios of ca. 1 and as a result the orientations of these molecules were entirely governed by 
interactions with the host molecules, greatly restricting the choice of host materials that could 
be used in devices. A possible solution to this is to greatly increase the aspect ratio of the 
emitting molecules, allowing alignment by other processes. A linear iridium complex it needs 
to be a heteroleptic complex with 2-phenylpyridine (ppy) and an ancillary ligand, e.g. 
acetylacetonate (acac) or picolinate (pic), and any extensions be made at the 4-postion of the 
ppy pyridine. Two examples of this type of modification have been reported Ir(2,4-
diphenylpyridine)2(acac) (Ir(Phppy)2(acac), λemis = 560 nm) and Ir(2-phenyl-4-
(phenylethynyl)pyridine)2(acac) (Ir(Ph-≡-ppy)2(acac), λemis = 570 nm),11, 12 with aspect ratios 
of 1.97 and 2.54 respectively, however, in both cases the emissions of the complexes were 
significantly redshifted relative to that of the parent complex Ir(ppy)2(acac) (λemis = 520 nm) 
due to the increased conjugation of the substituent on the pyridine ring as a molecules length 
increased, additionally with the increased flexibility of the molecules facilitating non-
radiative decay processes the photo luminescent quantum yields (ɸPL) decreased. Therefore, 
any substituent used to extend the aspect ratio of the molecules also needs to be electronically 
decoupled from the emissive center such that the photophysical properties of the core 
‘Ir(ppy)2L’ remains intact. Kozhevnikov and co-workers. has demonstrated that the 
decoupling can be achieved by adding a twist between the ppy ligand and the substituent, 
achieved by replacing the 4-phenyl group with a mesityl. The steric hindrance of the two 
ortho-methyl groups resulted in a twist of the molecule effectively decoupling and prevented 
red shifting of the emission, in fact a significant enhancement of ɸPL and increased solubility 
was observed.13 Therefore in this investigation we seek to improve the horizontal alignment 
of iridium based complexes by increasing the aspect ratio while maintaining the 
photophysical behavior of the parent compound by the inclusion of ‘twists’ that decouple the 
electronic properties of the substituents from the core complex. Ir(ppy)2(acac) based 
complexes were chosen to for the proof of concept because of their ease of synthesis and well 
established physical properties and a transition dipole moment perpendicular to the axis being 
lengthened.   
Experimental section 
Synthesis 
General details. NMR spectra were recorded in deuterated solvent solutions on a 
Varian VNMRS-600 spectrometer and referenced against solvent resonances (1H, 13C). 
ESMS data were recorded on a TQD mass spectrometer (Waters Ltd, UK) in either 
acetonitrile or methanol, GCMS data were recorded on Trace GCMS (ThermoFinnigan) 
GCMS recorded in DCM, ASAP data were recorded on a Xevo QTOF (Waters) high 
resolution, accurate mass tandem mass spectrometer equipped with Atmospheric Pressure 
Gas Chromatography (APGC) and Atmospheric Solids Analysis Probe (ASAP). MALDI data 
were recorded on a Bruker Autoflex II ToF/FoF spectrometer. Microanalyses were performed 
by Elemental Analysis Service, London Metropolitan University, UK or Elemental 
Microanalysis service, Durham University, UK.  
 
4-(4-((triisopropylsilyl)ethynyl)phenyl)pyridine. THF (dry, 50 mL) and Et3N (15 mL) 
were added to 4-(4-bromophenyl)pyridine (5.0 g, 21.5 mmol), Pd(PPh3)2Cl2 (1.1 g, 1.6 
mmol) and CuI (285 mg, 1.5 mmol). The solution was degassed by three freeze-pump-thaw 
cycles before triisopropylsilyl acetylene (5.60 mL, 4.55 g, 25 mmol) was added. The solution 
was heated to reflux for 16 hours before the solvent was removed. The product was purified 
via column chromatography on silica gel eluted with a solvent gradient from neat DCM to 
neat Et2O. The oil was dissolved in Et2O before etheryl hydrogen chloride was added, 
immediately forming a precipitate. This was continued until no additional precipitate formed. 
At this stage, the precipitate was collected by filtration. The white powder was dissolved in 
DCM and washed with an ammonium hydroxide solution. The organic layer was collected, 
dried over MgSO4 and the solvent removed, to give a colourless oil. Yield: 6.35 g (88 %). 1H 
NMR (700 MHz; CDCl3): δH 8.65 (d, J3HH = 6.0 Hz, 2H, Ha), 7.58-7.55 (m, 4H, Hc+Hd), 7.47 
(d, J3HH = 6.0 Hz, 2H, Hb), 1.13 (pseudo singlet, 21H, He+Hf) ppm. 13C{1H} NMR (176 
MHz; CDCl3): δC 150.2, 147.4, 137.7, 132.7, 126.7, 124.3, 121.3, 106.3, 92.6, 18.6, 11.2 
ppm. ES-MS: m/z 336.060 [M+H]+. Anal. Calc. for C22H29NSi: C, 78.75; H, 8.71; N, 4.17 
%. Found: C, 78.68; H, 8.82; N, 4.26 %. 
 4-(2-methyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine. The same procedure as for 
4-(4-((triisopropylsilyl)ethynyl)phenyl)pyridine, except 4-(4-bromo-2-methylphenyl)pyridine 
was used in place of 4-(4-bromophenyl)pyridine to give a colourless oil. Yield: 6.77 g (90 
%). 1H NMR (700 MHz; CDCl3): δH 8.63 (d, J3HH = 6.0 Hz, 2H, Ha), 7.40 (d, J4HH = 1.6 Hz, 
1H, He), 7.36 (dd, J
3
HH = 7.7 Hz, J
4
HH = 1.6 Hz, 1H, Hd), 7.20 (d, J
3
HH = 6.0 Hz, 2H, Hb), 
7.12 (d, J3HH = 7.8 Hz, 1H, Hc), 2.24 (s, 3H, Hf), 1.13 (pseudo singlet, 21H, Hg+Hh) ppm. 
13C{1H} NMR (176 MHz; CDCl3): δC 149.6, 149.0, 139.0, 135.0, 134.0, 129.6, 129.1, 123.9, 
123.6, 106.5, 91.3, 20.0, 18.6, 11.3 ppm. ES-MS: m/z 350.865 [M+H]+. Anal. Calc. for 
C23H31NSi: C, 79.02; H, 8.94; N, 4.01 %. Found: C, 79.16; H, 9.02; N, 4.15 %. 
 
4-(2,3,5,6-tetramethyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine. The same 
procedure as for 4-(4-((triisopropylsilyl)ethynyl)phenyl)pyridine, except 4-(4-iodo-2,3,5,6-
tetramethylphenyl)pyridine was used in place of 4-(4-bromophenyl)pyridine to give a 
colourless oil. Yield: 6.32 g (75 %). 1H NMR (700 MHz; CDCl3): δH 8.67 (d, J3HH = 5.0 Hz, 
2H, Ha), 7.05 (d, J
3
HH = 5.9 Hz, 2H, Hb), 2.48 (s, 6H, Hc), 1.88 (s, 6H, Hd), 1.15 (pseudo 
singlet, 21H, He+Hf) ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 150.7, 149.8, 139.2, 136.61, 
130.8, 124.6, 123.8, 105.3, 99.0, 18.7, 18.5, 17.8, 11.3 ppm. ES-MS: m/z 392.278 [M+H]+. 
Anal. Calc. for C26H37NSi: C, 79.73; H, 9.52; N, 3.58 %. Found: C, 79.67; H, 9.50; N, 3.52 
%. 
 
2-phenyl-4-(2,3,5,6-tetramethylphenyl)pyridine (L1H). 4-(2,3,5,6-
tetramethylphenyl)pyridine (5.0 g, 23.6 mmol) was dissolved in THF (100 mL) before the 
solution was cooled to -78 °C. Phenyllithium (1.9 M, 49.6 mL, 94.4 mmol) was added to the 
solution slowly. The temperature was maintained at -78 °C for 1 hour before being allowed to 
warm to room temperature. Stirring was continued for an additional 6 hours before the 
reaction was quenched by pouring the solution into water. The solution was extracted with 
DCM, dried over MgSO4 and the solvent removed. The product was purified by silica 
chromatography eluted with a solvent gradient from neat hexane to neat DCM, yielding a 
yellow oil. Yield: 2.85 g (42 %). 1H NMR (700 MHz; CDCl3): δH 8.74 (dd, J3HH = 4.9 Hz, 
J4HH = 0.9 Hz, 1H, Ha), 8.03 (d, J
3
HH = 8.0 Hz, 2H, Hd), 7.55 (s, 1H, Hc), 7.49-7.46 (m, 2H, 
He), 7.43-7.40 (m, 1H, Hf), 7.04-7.03 (m, 2H, Hb+Hj), 2.28 (s, 6H, Hg), 1.92 (s, 6H, Hh) ppm. 
13C{1H} NMR (176 MHz; CDCl3): δC 157.4, 151.6, 149.7, 139.5, 139.2, 133.9, 131.1, 129.0, 
128.7, 126.9, 123.2, 121.5, 20.0, 17.1 ppm. ES-MS: m/z 288.174 [M+H]+. Anal. Calc. for 
C21H21N: C, 87.76; H, 7.37; N, 4.87 %. Found: C, 87.60; H, 7.49; N, 4.87 %. 
 
2-phenyl-4-((triisopropylsilyl)ethynyl)pyridine (L2H). The same procedure as for 
L1H, except 4-((triisopropylsily)ethynyl)pyridine was used in place of 4-(2,3,5,6-
tetramethylphenyl)pyridine to give a yellow oil. Yield: 2.06 g (40 %). 1H NMR (700 MHz; 
CDCl3): δH 8.64 (dd, J3HH = 5.1 Hz, J4HH = 1.9 Hz,1H, Ha), 7.98 (d, J3HH = 8.0 Hz, 2H, Hd), 
7.75 (s, 1H, Hc), 7.48-7.45 (m, 2H, He), 7.42-7.40 (m, 1H, Hf), 7.26 (d, J
3
HH = 6.4 Hz, 1H, 
Hb), 1.15 (pseudo singlet, 21H, Hg+Hh) ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 157.8, 
149.8, 139.0, 132.4, 129.5, 129.0, 127.2, 124.5, 123.1, 104.6, 96.6, 18.9, 11.4 ppm. ES-MS: 
m/z 336.214 [M+H]+. Anal. Calc. for C22H29NSi: C, 78.75; H, 8.71; N, 4.17 %. Found: C, 
78.60; H, 8.83; N, 4.25 %. 
 
2-phenyl-4-(4-((triisopropylsilyl)ethynyl)phenyl)pyridine (L3H). The same procedure 
as for L1H, except 4-(4-((triisopropylsilyl)ethynyl)phenyl)pyridine was used in place of 4-
(2,3,5,6-tetramethylphenyl)pyridine to give a yellow oil. Yield: 3.48 g (55 %). 1H NMR (700 
MHz; CDCl3): δH 8.73 (d, J3HH = 5.1 Hz, 1H, Ha), 8.05 (d, J3HH = 8.0 Hz, 2H, Hd), 7.89 (s, 
1H, Hc), 7.64-7.60 (m, 4H, Hg+Hh), 7.51-7.49 (m, 2H, He), 7.45-7.43 (m, 1H, Hf), 7.40 (dd, 
J3HH = 5.1 Hz, J
4
HH = 1.7 Hz, 1H, Hb), 1.18 (pseudo singlet, 21H, Hi+Hj) ppm. 13C{1H} NMR 
(176 MHz; CDCl3): δC 158.2, 150.1, 148.3, 139.3, 138.1, 132.7, 129.0, 128.7, 127.0, 126.8, 
124.3, 119.9, 118.4, 106.4, 92.6, 18.7, 11.3 ppm. MS-ASAP: m/z 412.219 [M+H]+. Anal. 
Calc. for C28H33NSi: C, 81.69; H, 8.08; N, 3.40 %. Found: C, 81.75; H, 8.17; N, 3.44 %. 
 
4-(2-methyl-4-((triisopropylsilyl)ethynyl)phenyl)-2-phenylpyridine (L4H). The same 
procedure as for L1H, except 4-(2-methyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine was 
used in place of 4-(2,3,5,6-tetramethylphenyl)pyridine to give a yellow oil. Yield: 3.14 g (48 
%). %). 1H NMR (700 MHz; CDCl3): δH 8.72 (dd, J3HH = 5.1 Hz, J4HH = 0.8 Hz, 1H, Ha), 
8.01 (dd, J3HH = 7.0 Hz, 2H, Hd), 7.66 (s, 1H, Hc), 7.51-7.48 (m, 2H, He), 7.45-7.41 (m, 3H, 
Hf+Hh+Hi), 7.21 (d, J
3
HH = 7.8 Hz, 1H, Hg), 7.17 (dd, J
3
HH = 5.0 Hz, J
4
HH = 1.6 Hz,  1H, Hb), 
2.30 (s, 3H, Hj), 1.16 (pseudo singlet, 21H, Hk+Hi). 13C{1H} NMR (176 MHz; CDCl3): δC 
157.2, 149.9, 149.5, 139.3, 139.2, 135.1, 134.0, 129.7, 129.1, 129.0, 128.7, 126.9, 123.6, 
122.4, 120.9, 106.6, 91.3, 20.1, 18.6, 11.3 ppm. ES-MS: m/z 426.243 [M+H]+. Anal. Calc. 
for C29H35NSi: C, 81.82; H, 8.29; N, 3.29 %. Found: C, 81.90; H, 8.35; N, 3.46 %. 
 
2-phenyl-4-(2,3,5,6-tetramethyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine (L5H). 
The same procedure as for L1H, except 4-(2,3,5,6-tetramethyl-4-
((triisopropylsilyl)ethynyl)phenyl)pyridine was used in place of 4-(2,3,5,6-
tetramethylphenyl)pyridine to give a yellow oil. Yield: 4.50 g (41 %). 1H NMR (700 MHz; 
CDCl3): δH 8.75 (d, J3HH = 4.9 Hz, J4HH = 0.9 Hz, 1H, Ha), 8.02 (dd, J3HH = 7.0 Hz, J4HH = 1.2 
Hz, 2H, Hd), 7.50 (s, 1H, Hc), 7.49-7.46 (m, 2H, He), 7.43-7.40 (m, 1H, Hf), 7.00 (dd J
3
HH = 
4.9 Hz, J4HH = 1.5 Hz, 1H, Hb), 2.49 (s, 6H, Hg), 1.93 (s, 6H, Hh), 1.16 (pseudo singlet, 21H, 
Hi+Hj) ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 157.5, 151.5, 149.7, 139.5, 139.0, 136.6, 
130.9, 129.1, 128.7, 126.9, 123.8, 123.0, 121.2, 105.3, 99.0, 18.7, 18.5, 17.8, 11.3 ppm. MS-
ASAP: m/z 468.308 [M+H]+. Anal. Calc. for C32H41NSi: C, 82.17; H, 8.84; N, 2.99 %. 
Found: C, 81.99; H, 8.93; N, 3.22 %. 
 
Iridium coordination general procedure. IrCl3∙3H2O (408 mg, 1.1 mmol) was added to a 
solution containing L1H – L5H (3.48 mmol), ethoxyethanol (30 mL) and water (15 mL). The 
solution was heated to 110 °C for 12 hours before being cooled and poured into water (300 
mL), forming a precipitate. The precipitate was dissolved in DCM and dried over MgSO4 
before being passed through a silica plug. The residue was dissolved in ethoxyethanol (30 
mL), acetylacetone (5 mL) and K2CO3 (276 mg, 2.0 mmol) were added and the solution 
heated to 90 °C for 12 hours. The solution was cooled and poured into water (300 mL), 
forming a precipitate that was collected via filtration. The precipitate was dissolved in DCM 
and dried over MgSO4 before the product was purified via silica chromatography eluted by 
DCM, collecting the emissive band. 
 
Ir(L1)2(acac) (1). A bright green solid. Crystals were grown by evaporation of a 
DCM/hexane solution. Yield: 589 mg (62 %). 1H NMR (700 MHz; CD2Cl2): δH 8.59 (dd 
J3HH = 5.7 Hz, 2H, Ha), 7.69 (d, J
4
HH = 2.0 Hz, 2H, Hc), 7.55 (dd, J
3
HH = 7.8 Hz, J
4
HH = 1.7 
Hz,  2H, Hg), 7.09 (s, 2H, Hh), 7.03 (dd, J
3
HH = 5.8 Hz, J
4
HH = 1.8 Hz, 2H, Hb), 6.86 (td, J
3
HH 
= 7.4 Hz, J4HH = 1.7 Hz, 2H, Hf), 6.76 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.7 Hz, 2H, He), 6.41 (dd, 
J3HH = 7.8 Hz, J
4
HH = 1.6 Hz, 2H, Hd), 5.38 (s, 1H, Hm), 2.33-2.32 (m, 12H, Hi+Hj), 2.09 (s, 
6H, Hl or Hk), 2.02 (s, 6H, Hl or Hk), 1.88 (s, 6H, Hn) ppm. 13C{1H} NMR (176 MHz; 
CD2Cl2): δC 184.7, 168.1, 152.3, 147.9, 147.4, 145.3, 138.9, 133.9, 133.0, 131.2, 131.1, 
128.7, 123.8, 123.2, 120.7, 119.8, 100.4, 28.3, 19.8, 16.9 ppm. MS-MALDI: m/z 864.4 [M]+. 
Anal. Calc. for C47H47N2O2Ir: C, 65.33; H, 5.48; N, 3.24 %. Found: C, 65.29; H, 5.33; N, 
3.38 %.  
 
Ir(L2)2(acac) (2). A bright orange powder. Crystals were grown by evaporation of an 
acetonitrile solution. Yield: 0.57 g (60 %). 1H NMR (700 MHz; CD2Cl2): δH 8.43 (d, 
J3HH = 6.0 Hz, 2H, HA), 7.90 (d, J
4
HH = 1.7 Hz, 2H), 7.59 (dd, J
3
HH = 7.7 Hz, J
4
HH = 1.1 Hz, 
2H, HG), 7.20 (dd, J
3
HH = 6.0 Hz, J
4
HH = 1.7 Hz, 2H, HB), 6.87 (td, J
3
HH = 7.7 Hz, J
4
HH = 1.1 
Hz, 2H, HF), 6.71 (td, J
3
HH = 7.7 Hz, J
4
HH = 1.1 Hz, 2H, HE), 6.27 (dd, J
3
HH =  7.7 Hz, J
4
HH = 
1.1 Hz, 2H, HD), 5.28 (s, 1H, HJ), 1.80 (s, 6H, HK), 1.20 (m, 42 H, HH+I) ppm. 13C{1H} NMR 
(176 MHz; CD2Cl2): δC 184.9, 168.5, 147.8, 144.1, 133.3, 132.3, 129.5, 124.2, 124.0, 121.1, 
120.8, 104.0, 101.0, 98.9, 28.9, 18.8, 11.4 ppm. MS-MALDI: 960.2 [M]+. Anal. Calc. for 
C49H63N2IrO2Si2: C, 61.28; H, 6.61; N, 2.92 %. Found: C, 61.33; H, 6.70; N, 3.04 %. 
 
Ir(L3)2(acac) (3). A bright orange powder. Crystals were grown by the evaporation of 
a DCM solution. Yield: 831 mg (68 %). 1H NMR (700 MHz; CD2Cl2): δH 8.60 (d, 
J3HH = 6.0 Hz, 2H, Ha), 8.12 (s, 2H, Hc), 7.81 (d, J
3
HH = 8.0 Hz, 4H, Hj), 7.71 (d, 
J3HH = 7.9 Hz, J
4
HH = 1.3 Hz, 2H, Hg), 7.68 (d, J
3
HH = 8.0 Hz, 4H, Hi), 7.43 (dd, 
J3HH = 6.0 Hz, J
4
HH = 2.1 Hz, 2H, Hb), 6.90 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.2 Hz, 2H, Hf), 6.74 
(td, J3HH = 7.4 Hz, J
4
HH = 1.3 Hz, 2H, He), 6.37 (dd, J
3
HH = 6.0 Hz, J
4
HH = 1.2 Hz, 2H, Hd), 
5.32 (s, 1H), 1.85 (s, 6H), 1.19 (pseudo singlet, 42 H) ppm. 13C{1H} NMR (176 MHz; 
CD2Cl2): δC 184.8, 168.3, 148.4, 148.2, 147.5, 144.9, 137.1, 133.2, 132.6, 128.9, 127.0, 
124.8, 123.8, 120.8, 119.7, 115.9, 106.2, 100.3, 93.0, 28.3, 18.4, 11.3 ppm. MS-MALDI: 
1112.4 [M]+. Anal. Calc. for C61H71N2IrO2Si2: C, 65.85; H, 6.43; N, 2.52 %. Found: C, 
65.81; H, 6.60; N, 2.42 %. 
 
Ir(L4)2(acac) (4). A bright green powder. Crystals were grown by the slow 
evaporation of a benzene solution. Yield: 714 mg (57 %). 1H NMR (CD2Cl2) δ: 8.55 (d, 
J3HH = 5.7 Hz, 2H, Ha), 7.84 (s, 2H, Hc), 7.60 (dd, J
3
HH = 7.8 Hz, J
4
HH = 1.3 Hz, 2H, Hg), 7.52 
(s, 2H, Hk), 7.48 (dd, J
3
HH = 7.7 Hz, J
4
HH = 1.7 Hz, 2H, Hi), 7.39 (d, J
3
HH = 7.8 Hz, 2H, Hj), 
7.19 (dd, J3HH = 5.9 Hz, J
3
HH = 1.9 Hz, 2H, Hb), 6.87 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.3 Hz, 2H, 
Hf), 6.75 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.4 Hz, 2H, He), 6.37 (dd, J
3
HH = 7.7 Hz, J
4
HH = 1.2 Hz, 
2H, Hd), 5.35 (s, 1H, Ho), 2.44 (s, 6H, Hh), 1.86 (s, 6H, Hn), 1.18 (pseudo singlet, 42 H, 
Hl+Hm) ppm.
 13C{1H} NMR (176 MHz; CD2Cl2): δC 184.7, 167.9, 150.2, 147.6, 147.5, 145.0, 
138.7, 135.6, 134.1, 133.1, 129.6, 129.3, 128.8, 128.2, 123.8, 122.4, 120.8, 118.9, 106.5, 
100.4, 91.6, 28.3, 20.0, 18.4, 11.3 ppm. MS-MALDI: 1140.5 [M]+. Anal. Calc. for 
C63H75N2IrO2Si2: C, 66.34; H, 6.63; N, 2.46 %. Found: C, 66.47; H, 6.75; N, 2.59 %. 
 
Ir(L5)2(acac) (5). A bright green powder. Yield: 552 mg (41%). 1H NMR (700 MHz; 
CD2Cl2): δH 8.58 (d, J3HH = 6.0 Hz, 2H, Ha), 7.66 (s, 2H, Hc), 7.54 (dd, J3HH = 7.8 Hz, 
J4HH = 1.4 Hz, 2H, Hg), 7.00 (dd, J
3
HH = 5.7 Hz, J
4
HH = 1.8 Hz, 2H, Hb), 6.86 (td, 
J3HH = 7.4 Hz, J
4
HH = 1.3 Hz, 2H, Hf), 6.76 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.3 Hz, 2H, He), 6.39 
(dd, J3HH = 7.7 Hz, J
4
HH = 1.2 Hz, 2H, Hd), 5.37 (s, 1H, Ho), 2.55-2.54 (m, 12H, Hh+Hi), 2.11 
(s, 6H, Hj or Hk), 2.04 (s, 6H, Hj or Hk), 1.87 (s, 6H, Hn), 1.20 (pseudo singlet, 42H, Hl+Hm) 
ppm. 13C{1H} NMR (176 MHz; CD2Cl2): δC 184.7, 168.2, 152.0, 148.0, 147.4, 145.2, 139.0, 
136.6, 133.0, 131.1, 128.8, 123.9, 123.7, 123.0, 120.7, 119.6, 105.4, 100.4, 99.0, 28.3, 18.5, 
18.3, 17.7, 11.4 ppm. MS-MALDI: m/z 1224.5 [M]+. Anal. Calc. for C69H87N2O2Si2Ir: C, 
67.66; H, 7.16; N, 2.29 %. Found: C, 67.49; H, 6.93; N, 2.36 %. 
 
Sonogashira coupling general procedure. THF (50 mL) and Et3N (5 mL) were added to 
TIPS protected complex 2-5 (0.20 mmol), 4-tert-butyliodobenzene or 1-(tert-butyl)-4-((4-
iodophenyl)ethynyl)benzene (0.50 mmol), Pd(PPh3)4 (46 mg, 0.04 mmol) and CuI (8 mg, 
0.04 mmol). The solution was degassed by three freeze-pump-thaw cycles, before 
tetrabutylammonium fluoride (1.0 M in THF, 0.50 mL, 0.50 mmol) was added. The solution 
was stirred at room temperature for 12 hours before the solvent was removed. The residue 
was purified by silica chromatography eluted by DCM, collecting the emissive band.  
 
Ir(L6)2(acac) (6). An orange solid. Yield: 158 mg (87 %).
 1H NMR (700 MHz; 
CDCl3): δH 8.46 (d, J3HH = 5.9 Hz, 2H, Ha), 7.92 (s, 2H, Hc), 7.57-7.53 (m, 6H, Hg+Hh), 7.44 
(d, J3HH = 8.0 Hz, 4H, Hi), 7.18 (dd, J
3
HH = 5.9 Hz, J
4
HH = 1.9 Hz, 2H, Hb), 6.82 (td, 
J3HH = 7.8 Hz, J
4
HH = 1.2 Hz, 2H, Hf), 6.72 (td, J
3
HH = 7.7 Hz, J
4
HH = 1.3 Hz, 2H, He), 6.31 
(dd, J3HH = 7.7 Hz, J
4
HH = 1.2 Hz, 2H, Hd), 5.21 (s, 1H, Hk), 1.79 (s, 6H, Hl), 1.35 (s, 18H, Hj) 
ppm. 13C{1H} NMR (176 MHz; CD2Cl2): δC 184.8, 167.9, 153.1, 147.7, 147.4, 144.4, 136.9, 
133.1, 132.5, 131.7, 129.0, 127.5, 125.6, 123.9, 123.5, 120.9, 120.3, 118.7, 100.3, 96.1, 85.8, 
34.8, 30.8, 28.2 ppm. MS-MALDI: m/z 912.4 [M]+. Anal. Calc. for C51H47N2IrO2∙¾CH2Cl2: 
C, 63.69; H, 5.01; N, 2.87 %. Found: C, 63.40; H, 5.38; N, 2.89 %. 
 
Ir(L7)2(acac) (7). A red powder. Crystals were grown by the evaporation of a 
DCM/Hexane solution. Yield: 200 mg (90 %). 1H NMR (700 MHz; CDCl3): δH 8.48 (d, 
J3HH = 5.9 Hz, 2H, Ha), 7.93 (d, J
4
HH = 1.8 Hz, 2H, Hc), 7.59-7.55 (m, 10H, Hg+Hi+Hk), 7.48 
(d, J3HH = 8.2 Hz, 4H, Hj), 7.39 (d, J
3
HH = 8.2 Hz, 2H, Hk), 7.19 (dd, J
3
HH = 5.8, J
4
HH = 1.8 
Hz, 2H, Hb), 6.82 (td, J
3
HH = 7.4, J
4
HH = 1.2 Hz, 2H, Hf), 6.72 (td, J
3
HH = 7.4, J
4
HH = 1.2 Hz, 
2H, He), 6.30 (dd, J
3
HH = 7.8, J
4
HH = 1.1 Hz, 2H, Hd), 5.22 (s, 1H, Hm), 1.80 (s, 6H, Hn), 1.33 
(s, 18H, Hl) ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 184.7, 168.5, 151.9, 147.7, 143.9, 
133.0, 131.9, 131.6, 131.4, 129.4, 125.4, 124.6, 123.2, 121.3, 120.9, 120.3, 119.7, 100.4, 95. 
MS-MALDI: m/z 1112.3 [M]+. Anal. Calc. for C67H55N2IrO2∙1¼CH2Cl2: C, 67.27; H, 4.76; 
N, 2.30 %. Found: C, 67.06, H; 4.67; N, 2.31 %. 
 
Ir(L8)2(acac) (8). An orange powder.
 Yield: 189 mg (89 %). 1H NMR (700 MHz; 
CD2Cl2): δH 8.57 (d, J3HH = 6.0 Hz,  2H, Ha), 8.13 (d J4HH = 2.0 Hz, 2H, Hc), 7.85 (d, J3HH = 
8.0 Hz, 4H, Hh), 7.74 (d, J
3
HH = 8.0 Hz, 4H, Hi), 7.71 (d, J
3
HH = 8.0 Hz, 2H, Hg), 7.53 (d, 
J3HH =  8.0 Hz, 4H, Hj), 7.46-7.43 (m, 6H, Hb+Hk), 6.90 (td, J
3
HH = 7.1 Hz, J
4
HH = 1.3 Hz, 
2H, Hf), 6.74 (td, J
3
HH = 7.1 Hz, J
4
HH = 1.3 Hz,  2H, He), 6.36 (dd, J
3
HH = 7.9 Hz, J
4
HH = 1.2 
Hz, 2H, Hd), 5.34 (s, 1H, Hm), 1.85 (s, 6H, Hn), 1.34 (s, 18H, Hl) ppm. MS-MALDI: m/z 
1065.1[M]+. Anal. Calc. for C63H54IrN2O2: C, 71.16; H, 5.12; N, 2.63 %. Found: C, 71.19, 
H, 5.18; N, 2.41 %. Unable to obtain 13C NMR due to low solubility. 
 
Ir(L9)2(acac) (9). Purification achieved by washing the powder by methanol followed 
by DCM to give a bright orange powder. Yield: 232 mg (92 %). MS-MALDI: m/z 1264.4 
[M]+. Anal. Calc. for C79H63IrN2O2·1¾CH2Cl2: C, 68.62; H, 4.74; N, 1.98 %. Found: C, 
68.62; H, 4.41; N, 2.30 %. Unable to obtain 1H or 13C NMR due to low solubility. 
 
Ir(L10)2(acac) (10). A green solid. Yield: 159 mg (73 %). 1H NMR (700 MHz; 
CD2Cl2): δH 8.57 (d, J3HH = 6.0 Hz, 2H, Ha), 7.88 (d, J4HH = 1.9 Hz, 2H, Hc), 7.62 (dd, J3HH = 
7.8 Hz, J4HH = 1.3Hz, 2H, Hg), 7.58 (s, 2H, Hj), 7.54-7.52 (m, 6H, Hh+Hl), 7.46 (m, 6H, 
Hj+Hm), 7.22 (dd, J
3
HH =5.8 Hz, J
4
HH = 2.0 Hz, 2H, Hb), 6.88 (td, J
3
HH = 7.5 Hz, J
4
HH =1.2 
Hz, 2H, Hf), 6.76 (td, J
3
HH = 7.5 Hz, J
4
HH =1.2 Hz, 2H, He), 6.38 (dd, J
3
HH = 7.7 Hz, 
J4HH =1.2 Hz, 2H, Hd), 5.36 (s, 1H, Ho), 2.47 (s, 6H, Hk), 1.88 (s, 6H, Hp), 1.36 (s, 18 H, Hn) 
ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 184.7, 167.9, 151.9, 150.2, 147.6, 147.5, 145.0, 
138.4, 135.7, 133.7, 133.1, 131.2, 129.5, 129.2, 128.8, 125.4, 128.8, 122.4, 120.8, 119.9, 
118.9, 100.4, 90.3, 88.1, 34.7, 30.8, 28.3, 17.4 ppm. MS-MALDI: m/z 1093.2 [M]+. Anal. 
Calc. for C65H49IrN2O2: C, 71.47; H, 5.44; N, 2.56 %. Found: C, 71.34; H, 5.59; N, 2.62 %. 
Ir(L11)2(acac) (11). A green powder. Yield: 235 mg (91 %). Yield: 1H NMR (700 
MHz; CD2Cl2): δH 8.56 (d, J3HH = 6.2 Hz, 2H, Ha), 7.87 (d, J4HH = 1.8 Hz, 2H, Hc), 7.62-7.54 
(m, 14 H, Hg+Hh+Hj+Hl+Hm), 7.50 (d, J
3
HH = 6.2 Hz, 4H, Hn), 7.44 (d, J
3
HH = 7.7 Hz, 2H, 
Hi), 7.42 (d, J
3
HH = 8.2 Hz, 4H, Ho), 7.22 (dd, J
3
HH = 5.8 Hz, J
4
HH = 2.0  Hz, 2H, Hb), 6.88 
(td, J3HH = 7.8 Hz, J
4
HH = 1.3 Hz, 2H, Hf), 6.76 (td, J
3
HH = 7.8 Hz, J
4
HH = 1.3 Hz, 2H, He), 
6.37 (dd, J3HH = 7.7 Hz, J
4
HH = 1.2 Hz, 2H, Hd), 5.36 (s, 1H, Hq), 2.47 (s, 6H, Hk), 1.87 (s, 
6H, Hr), 1.33 (s, 18H, Hp) ppm.
i MS-MALDI: m/z 1292.4 [M]+. Anal. Calc. for 
C81H67IrN2O2·CH2Cl2: C, 71.49; H, 5.05; N, 2.03 %. Found: C, 71.51; H, 4.88; N, 2.05 %. 
 
Ir(L12)2(acac) (12). A green powder. Crystals were grown by the evaporation of a 
DCM/MeOH solution. Yield: 183 mg (78 %). 1H NMR (700 MHz; CD2Cl2): δH 8.59 (d, 
J3HH = 5.7 Hz, 2H, Ha), 7.69 (d, J
4
HH =1.8 Hz, 2H, Hc), 7.57 – 7.54 (m, 6H, Hg+Hl), 7.44 (d, 
J3HH = 7.9 Hz, 4H, Hm), 7.03 (dd J
3
HH = 5.7 Hz, J
4
HH = 1.8 Hz, 2H, Hb), 6.86 (td, J
3
HH = 7.4 
Hz, J4HH = 1.2 Hz, 2H, Hf), 6.76 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.2 Hz, 2H, He), 6.40 (dd, J
3
HH = 
7.7 Hz, J4HH = 1.2 Hz, 2H, Hd), 5.37 (s, 1H, Ho), 2.60-2.58 (m, 12H, Hi+Hk), 2.14 (s, 6H, Hh 
or Hj), 2.07 (s, 6H, Hh or Hj), 1.88 (s, 6H, Hp), 1.36 (s, 18H, Hn) ppm. 13C{1H} NMR (176 
MHz; CDCl3): δC 184.7, 168.2, 152.0, 151.6, 148.0, 147.4, 145.2, 138.9, 136.2, 136.1, 133.0, 
131.2, 131.1, 130.9, 128.8, 125.4, 123.9, 123.5, 123.0, 120.7, 120.6, 119.6, 100.4, 97.5, 87.5, 
34.6, 30.8, 28.3, 18.2, 17.7 ppm. MS-ASAP: m/z 1176.515 [M]+. Anal. Calc. for 
C71H71N2O2Ir: C, 72.48; H, 6.08; N, 2.38 %. Found: C, 72.62; H, 5.93; N, 1.92 %.  
 
Ir(L13)2(acac) (13). A green powder.
 Crystals were grown by the evaporation of a 
DCM/MeOH solution. Yield: 233 mg (85 %). 1H NMR (700 MHz; CD2Cl2): δH 8.60 (d, 
J3HH = 6.0 Hz, 2H, Ha), 7.70 (s, 2H, Hc), 7.61-7.56 (m, 10H, Hg+Hl+Hm), 7.50 (d, J
3
HH = 7.8 
Hz, 4H, Hn), 7.42 (d, J
3
HH =  7.8 Hz, 4H, Ho), 7.04 (dd, J
3
HH = 5.7 Hz, J
4
HH =  1.9 Hz, 2H, 
Hb), 6.87 (td, J
3
HH = 7.4 Hz, J
4
HH = 1.2 Hz, 2H, Hf), 6.77 (td J
3
HH = 7.4 Hz, J
4
HH = 1.2 Hz, 
2H, He), 6.41 (dd, J
3
HH = 7.8 Hz, J
4
HH = 1.3 Hz, 2H, Hd), 5.38 (s, 1H, Hq), 2.63-2.60 (m, 12 
H, Hi+Hk), 2.14 (s, 6H, Hj or Hh), 2.08 (s, 6H, Hj or Hh), 1.88 (s, 6H, Hr), 1.35 (s, 18H, Hp) 
ppm. 13C{1H} NMR (176 MHz; CDCl3): δC 184.8, 168.2, 152.0, 148.0, 147.4, 145.2, 139.3, 
136.4, 133.0, 131.4, 131.2, 128.8, 125.4, 123.9, 123.4, 123.1, 123.0, 120.8, 119.8, 119.6, 
100.4, 97.0, 91.3, 90.2, 88.3, 34.7, 30.8, 28.3, 18.3, 17.7 ppm. MS-MALDI: m/z 1376.4 
[M]+. Anal. Calc. for C87H79N2O2Ir·CH2Cl2: C, 72.31; H, 5.59; N, 1.92%. Found: C, 72.31; 
H, 5.78; N, 1.92%.  
 
X-ray Crystallography  
The X-ray single crystal data have been collected using λMoKα radiation (λ =0.71073Å) on a 
Bruker D8Venture (Photon100 CMOS detector, IμS-microsource, focusing mirrors) ( 
compounds L1HA, 1, 3, 7 and 12) Bruker SMART CCD 6000 (fine-focus sealed tube, 
graphite monochromator, MonoCap optics) (compounds 4 and 7) and Agilent XCalibur 
(Sapphire-3 CCD detector, fine-focus sealed tube, graphite monochromator) (4-(2,3,5,6-
tetramethylphenyl)pyridine, 4-(2,3,5,6-tetramethyl-4-
((triisopropylsilyl)ethynyl)phenyl)pyridine and L1HB) diffractometers equipped with a 
Cryostream (Oxford Cryosystems) open-flow nitrogen cryostats at the temperature 
120.0(2)K. All structures were solved by direct method and refined by full-matrix least 
squares on F2 for all data using Olex214 and SHELXTL15 software. All non-disordered non-
hydrogen atoms were refined anisotropically, hydrogen atoms in structures 4-(2,3,5,6-
tetramethylphenyl)pyridine and L1HA were refined isotropically; hydrogen atoms in other 
structures were placed in calculated positions and refined in riding mode. The crystals 1 and 
13 contain severely disordered solvent molecules (most probably DCM) that could not be 
modelled properly. Their contribution to the scattering was taken into account by application 
a MASK procedure of Olex2 program package. 
Crystal data and parameters of refinement are listed in Table S1-3. Crystallographic data for 
the structure have been deposited with the Cambridge Crystallographic Data Centre as 
supplementary publication CCDC-1837878-1837887. 
 
Instrumentation  
All the photophysical measurements of iridium complexes were performed using 
DCM as the solvent. The UV-Visible spectra were measured on a Unicam UV2-100 
spectrometer operated with the Unicam Vison software in quartz cuvettes with path length l = 
1 cm.  
Excitation and emission photoluminescence spectra were recorded on a Horiba Jobin Yvon 
SPEX Fluorolog 3-22 spectrofluorometer. Samples were degassed by repeated freeze-pump-
thaw cycles using a turbomolecular pump until the pressure was stable in quartz cuvettes, l = 
1 cm. The solutions had absorbance below 0.15 to minimise inner filter effects. PLQYs were 
measured following the method of Resch-Genger et al.16 
 
Emission lifetimes were recorded by exciting the sample with the output of a pulsed laser 
diode which produced a 1 kHz train of pulses of 20 ns duration at 405 nm. The luminescence 
was collected at 90° and focused onto the entrance slit of a monochromator (Betham TM-
300V). The emission was detected by a photon-counting PMT and the arrival times of 
photons at the detector were determined using a digital oscilloscope (NI-5133) configured as 
a virtual multichannel by LabVIEW. The data were transferred to a PC and analysed using 
non-linear regression to a single exponential decay, and the quality of fit established by 
reduced χ2 and random residuals. The samples were degassed by repeated freeze-pump-thaw 
cycles in duplicates. The decay data were fitted to exponential functions. 
Electrochemical analyses of the iridium complexes were carried out using a PalmSens 
EmStat2 potentiometer, with platinum working, platinum counter and platinum pseudo 
reference electrodes, from solutions in DCM containing 0.1 M supporting electrolyte 
(tetrabutylammonium hexafluorophospate, TBAPF6), scan rate = 100 mV s
-1. The 
ferrocene/ferrocinium couple was used as the internal reference. 
 
Computational 
Density functional theory (DFT) calculations were carried out using the Gaussian 09 
package (Gaussian, Inc)17, all results were displayed using GaussView18 and GaussSum19. All 
calculations used the B3LYP level set employing a 6-31G(d)/LANL2DZ basis set, 
geometrically optimised in a DCM solvent field using the SCRF-PCM method, with energy 
minima confirmed by frequency calculations.  
 
RESULTS AND DISCUSSION 
 Synthesis. 5 new ligands (L1H-L5H) were synthesized by a combination of Suzuki-
Miyrua, Sonogahira couplings, and phenylation reactions. L2H was readily synthesized by 
phenylation of  4-(triisopropylsilyl)ethynyl-pyridine using phenyllithium as described 
previously by Edkins.20 L1,3-5H required a Suzuki reaction with either 4-pyridylboronic acid 
(L3H), previously reported by Marks,21 or 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pyridine (L1, 4, 5H) with bromodurene (L1H), 1,4-bromo-iodo-benzene (L3H) or 2-iodo-5-
bromo-toluene (L4H) to give the respective 4-(4-bromophenyl)pyridine that was in turn 
reacted via a Sonogashira coupling to yielding the respective 4-(4-
((triisopropylsilyl)ethynyl)phenyl)pyridine that was finally phenyllated as with L1H. An 
attempt to make 4-(4-bromo-2,6-dimethylphenyl)pyridine was made via a Suzuki between 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine and 5-bromo-2-iodo-1,3-
dimethylbenzene, however, due to the steric hindrance from the ortho-methyl groups the 
reactivity of the iodo group was reduced resulting in the production of 4-(4-iodo-3,5-
dimethylphenyl)pyridine that could not be separated from the desired product. When 1-
bromo-4-iodo-durene was used in place of 5-bromo-2-iodo-1,3-dimethylbenzene the 
selectivity of the iodo group was restored allowing for the selective synthesis of 4-(4-bromo-
2,3,5,6-tetramethylphenyl)pyridine, however, the subsequent Sonogashira reaction between 
this and triisopropylsilyl acetylene (TIPSCCH) did not proceed, likely again due to the 
reduced reactivity of the bromine and increased steric hindrance. Therefore, 4-(4-iodo-
2,3,5,6-tetramethylphenyl)pyridine was prepared according to Yamashita’s method of 
reacting 3 equivalents of diiododurene with 1 equivalent 4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pyridine.22 The increased reactivity of the iodo group allowed the 
Sonogashira reaction to proceed in reasonable yields (75%), although it was necessary to heat 
the reaction to 70°C to achieve this. As with the other ligands the L5H was produced by 
phenyllating 4-(2,3,5,6-tetramethyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine with 
phenyllithium. 
 
Scheme 1. Schematic diagram for ligand (L1-L5H) synthesis where L1H (R1 = R2= R3= R4 = 
CH3, X1 = Br, X2 = H), L
3H (R1 = R2= R3= R4 = H, X1 = I, X2 =Br), L
4H (R1 = CH3, R2= R3= 
R4 = H, X1 = I, X2 =Br), L
5H (R1 = R2= R3= R4 = CH3, X1 = I, X2 =I); i) Pd(PPh3)4, K2CO3, 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, DMF; ii) TIPSCCH, CuI, Pd(PPh3)4, 
THF, iPr2NH; iii) PhLi, THF.   
 
The iridium complexes 1-5 were synthesized using standard conditions, reacting the 
respective ligand (L1-L5H) with IrCl3∙3H2O in 2-ethoxyethanol and water to form the μ-
chloro dimer, followed by the coordination of the ancillary acac ligand using K2CO3 and 
acetylacetone. To produce the extended complexes 6-12 the complexes 2-5 were 
deproptected in situ using tetrabutylammonium fluoride (TBAF) to give the corresponding 
terminal alkyne making it available for Sonogashira reactions. In this case we chose to use 4-
(tert-butyl)iodobezene (to give the complexes 6, 8, 10 and 12) or 1-(tert-butyl)-4-((4-
iodophenyl)ethynyl)benzene yielding complexes 7, 9, 11 and 13.  These groups were chosen 
as the increase the aspect ratio of the complexes and to attempt to enhance solubility.   
Despite the inclusion of a tertiary butyl group to maintain solubility complex 9 was too 
insoluble for even 1H NMR so could only be characterized by elemental analysis and mass-
spectrometry. However, as was observed by Kozhevnikov et al. the inclusion of a twist in the 
iridium complex can greatly improve its solubility in particular complexes 10, 11, 12 and 
13.13 
 
Scheme 2. Synthesis of complexes 1-5 and their post-synthetic modification to give 
complexes 6-13. Where 2 (Rˈ = TIPS ), 3 (Rˈ = TIPS), 4 (Rˈ = TIPS), 5 (Rˈ = TIPS), 6 (Rˈ = 
a), 7 (Rˈ = b), 8 (Rˈ = a),  9 (Rˈ = b), 10 (Rˈ = a),  11 (Rˈ = b), 12 (Rˈ = a), and  13 (Rˈ = b); i) 
IrCl3·3H2O, 2-ethoxyethanol and water; ii) acetylacetone, K2CO3 and 2-ethoxyethanol; iii) 
TBAF, CuI, Pd(PPh3)4, THF, 
iPr2NH and 1-(tert-butyl)-4-iodobenzene (6, 8, 10 and 12) or 1-
(tert-butyl)-4-((4-iodophenyl)ethynyl)benzene (7, 9, 11 and 13). 
Molecular Structures 
Crystal structures of compounds 4-(2,3,5,6-tetramethylphenyl)pyridine, 4-(2,3,5,6-
tetramethyl-4-((triisopropylsilyl)ethynyl)phenyl)pyridine, L1H (two polymorphs) and 
complexes 1, 3, 4, 7, 12, and 13 have been determined by single-crystal X-ray diffraction 
method. The free ligand L1H exists in two polymorph modifications. The conformation of 
molecules of two polymorphs is different: the torsion angles around the C-C bonds between 
pyridine ring and substituted and unsubstituted Ph-rings are 79.9(2), 32.2(2) and 88.8(4), 
14.4(5) in each of the polymorphs respectively. The packing of the molecules L1H in both 
polymorphs are determined mainly by C(Ph)-H…N interactions but packing motifs are quite 
different probably because in one of the polymorphs the m-H atom of Ph-group participate in 
intermolecular contacts while in the second one the corresponding p-H atom form the link with 
the adjacent Py-ring. Interestingly, no π…π interactions have been found in the discussed 
structures.  
The crystal structure of complex 1 contains 3.5 independent molecules (one of the complexes 
is located in a special position on a 2-fold axis). The independent complexes 1 differ by 
orientation of duryl-groups, indicating conformational flexibility of the L1H ligand: 
corresponding torsion angles vary from 63.8 to 89.0. Crystal structure of complex 3, showing 
severe disorder of the terminal acetyl TIPS-groups, also contains 2 crystallographically 
independent molecules. The complexes 3 and DCM solvent molecules are linked by various 
CH…O and π…π interactions into diffuse layers, separated by the hydrophobic areas formed 
out of i-Pr-groups. Similar packing pattern is also observed in the structure 4, however the 
CH…O interactions there are replaced by CH...π ones and the benzene solvent molecules are 
filling the voids. The introduction of Me-group in the side chain predictably increases torsion 
angle around the bond between corresponding aromatic rings from av. 27 in 3 to 40 in 4. 
Complex 7 shows great conformational lability of terminal aromatic rings which form the 
interplanar angles with adjacent middle rings of 7.8 and 81.7. Pyridine and duryl rings in 
molecule 12 in crystal form interplanar angles -77.8(7) and -65.3(7), the values close to those 
found in the complex 1, while the terminal phenyl rings rotate relatively to the duryl ring by -
37.4(6) and -11.7(6). Double π…π interactions link molecules 12 in crystal in 
centrosymmetric dimers, while various CH…O and CH…π contacts form a further 3D-
network. Quite similar molecular conformation is adopted by complex 13. The molecule in the 
crystal is noticeably bent and the terminal rings are significantly differently orientated 
relatively to the “middle” rings of the ligand: the corresponding torsion angles are -47.0(7) and 
-18.4(9), indicating unrestricted mutual rotation of these aromatic fragments. Interestingly, 
there are no short distinctive direction-specific intermolecular contacts in structure 13, the 
complexes and DCM solvent molecules are loosely linked by weak CH…π and CH…O 
interactions. Indeed, the density of crystal packing of complex 13 is just 57.8% (the 
corresponding values for structures 3, 4, 7 and 12 are 69.3, 65.0, 62.4 and 62.8%). Thus the 
molecular structures of the structurally studied complexes indicate low rotation barrier of 
unsubstituted aromatic rings around the ethynyl links. 
 Figure 1. Crystal structure of 3, solvent molecule and disorder removed for clarity, thermal 
ellipsoids displayed at 50% probability. 
 
Figure 2. Crystal structure of 7, solvent molecule removed for clarity, thermal ellipsoids 
displayed at 50% probability. 
 
Figure 3. Crystal structure of 13, solvent molecule and disorder removed for clarity, thermal 
ellipsoids displayed at 50% probability. 
Computational 
A brief investigation was performed using DFT calculations to study the electronic 
structure of 1-13 and iridium(III)bis(2,4-diphenylpyridine)(acetylacetone) (Ir(Phppy)2(acac)). 
Initial geometries for complexes were based on the crystallographic structures of 1-5, 7, 12 
and 13. As is typical for iridium(III)(bis(2-phenylpyridine))-type complexes the HOMO is 
dominated by iridium and phenylate (ppy) character, with no effects occurring as a result of 
modification about the pyridine. Calculated HOMO energies remain in the range -5.07 – -
5.17 eV. The LUMO for each of the complexes is significantly dependent on the 
modifications made about the pyridine. For each of the complexes 2-4 and 6-10 as the 
substituent attached was increased in length the LUMO energy was lowered and the relative 
contribution from the substituents increased, e.g. 2 (-1.94 eV, 66% Py, 21% R), 6 (-2.02 eV, 
54 % Py, 36 % R) and 7 (-2.26 eV, 37 % Py, 57 % R). This occurs for each of the compounds 
with -, -C6H4- and –otol- barrier, indicating that there is conjugation between these peripheral 
groups and the pyridine ring. However, when durene was used, complexes 1, 5, and 12 the R 
group was electronically decoupled, as a result the LUMO energy remained -1.44(1) – -1.48 
(5) eV for all the variations and the orbital remains 64 – 65 % Py and 28 – 29 % Ph in 
character more characteristic of the unsubstituted Ir(ppy)2(acac). The behavior changes 
abruptly for 13, with the further extension of the substituent results in a lowering of the R 
groups orbital energy to the point that both the LUMO and LUMO+1 are 99% substituent in 
character and remaining electronically decoupled from the Ir(ppy)2(acac) center of the 
complex. 
 Figure 4. LUMO orbital diagram: a) complex 7, b) complex 12, c) complex 13. 
Electrochemistry 
Cyclic voltammograms were recorded for all of the complexes in 0.1 M TBAPF6 in 
dichloromethane, and referenced against ferrocene (i.e. E½ FeCp2 / [FeCp2]
+ = 0.00 V). Each 
of the iridium complexes (1-13) show a single oxidation attributed primarily attributed to the 
Ir(III)/Ir(IV) couple. No reduction waves were observed within the solvent working range. 
The oxidation potential of the metal only ranges from 0.33 V (1) to 0.35 V (3) for all the 
complexes 1, 3-5 and 8-13 and is effectively independent of the extended conjugation in the 
complex. However, the complexes without an aromatic spacer (2, 6 and 7) have slightly 
higher oxidation potentials 0.36-0.38 V, this may be the result of the increased conjugation of 
the alkyne compared that of the aromatic groups but does not increase significantly as a result 
of replacing a TIPS group with a 1-(tert-butyl)-4-(phenylethynyl)benzene supporting that the 
oxidation was localized to the Ir(ppy)2(acac) center and the alkyne is acting as an electron 
withdrawing group.   
 
Photophysical Properties 
Each of the complexes 1–13 were shown to have a strong single emission ranging from 520–
611 nm. In each case, the emission profile was broad and featureless, consistent with the 
emission being predominantly 3MLCT in nature, consistent with the τ0 values of 1.25–3.29 µs 
for all complexes except 13. The complexes with the alkyne directly attached to the pyridine 
(2, 6, and 7) showed a progressive red-shift as the molecules increased in length, as per 
Ir(ppy)2(acac) (λemis = 520 nm, end-to-end length = 9.53 Å):23 complex 2 (λemis = 582 nm, 
end-to-end length = 18.79 Å); complex 6 (λemis = 585 nm, end-to-end length = 26.21 Å); and 
complex 7 (λemis = 611 nm, end-to-end length = 39.93 Å). This result is consistent with the 
extended conjugation of the molecule, which results in a lowering of the lowest unoccupied 
molecular orbital (LUMO) energy.  
Furthermore, as the molecules become longer, the number of accessible vibrational modes 
increased along with knr, resulting in both their ɸPL and lifetimes, τp, decreasing. The phenyl 
(complexes 3, 8, and 9) and o-tolyl (complexes 4, 10, and 11) groups both showed less 
significant red shifts with increased molecular length than complexes without the spacer, and 
relative to the parent molecule, e.g. phenyl Ir(Phppy)2(acac) λemis = 560 nm:23 complex 9 
(λemis = 603 nm); otolyl Ir(otolppy)2(acac) (λemis = 547 nm);24 and complex 11 (λemis = 574 
nm). However, complexes with a duryl spacer showed negligible change, i.e. complex 1 (λemis 
= 520 nm), and complex 13 (λemis = 524 nm), attributed to the rotational restriction of the 
spacer. As the rotation becomes progressively hindered, the torsional angle between the ppy 
ligand and the aromatic spacer increases (dur>o-tol>Ph), and the conjugation between the 
ppy ligand and the substituents decreases.  
In poly(butyl-co-isobutyl methacrylate) (PBiBM) films, the emissions showed a small  blue-
shift relative to those recorded in dichloromethane (DCM) solutions e.g. 6 (λemis(film) = 553 
nm) and 7 (λemis(film) = 557 nm) giving a ΔE = 0.016 eV compared to a ΔE = 0.090 eV in 
solution. This occurs for two reasons: i) the 3MLCT emission character is solvatochromic,12 
and ii) the increased rigidification of the polymer significantly reduces the rotational freedom 
of the alkynes, and as a result, hinders charge transfer.  
Complexes 7 (ɸPL = 0.38) and 9 (ɸPL = 0.28) showed a lower ɸPL compared to that of their 
shorter analogues, complexes 6 (ɸPL = 0.54) and 8 (ɸPL = 0.54). This is attributed to the 
increased modes of rotation resulting from the extended substituents acting as free rotors 
about the alkyne bonds increasing the non-radiative decay (complex 7, knr = 8.99×10
5 s-1; 
complex 9, knr = 7.83×10
5 s-1). For complexes 10–13, the substituents sufficiently decoupled 
from the excited state of the complex to negate such energy loses. The TIPS-protected 
complexes (2, 3, 4, and 5) had ɸPL values of ca., 0.20 higher than the ethynyl-phenylene 
substituted complexes; this result may be due to the TIPS groups protecting the phosphor 
center from solvent collisions.  
The pure radiative emission lifetimes, τ0, for all of the iridium complexes (1–12) were 1.5- 
3.3 µs, typical of iridium(C^N)2(acac) systems. However, complex 13 had a longer lifetime of 
27.5 µs in solution but reduced to 2.23 µs in a PBiBM film,  indicative of a system exhibiting 
either LC type emission or reversible electronic energy transfer (REET),25-28 In the latter a 
section of the molecule acts as a triplet sensitizer that is tethered but only weakly coupled to a 
phosphorescent emitter, and that the two components have triplet states that are thermally 
accessible to one another. The substituent of complex 13 (ET1 = 2.53 eV, see Table 1), which 
is electronically decoupled from the pyridine ring of the complex is effectively 4-((4-((4-(tert-
butyl)phenyl)ethynyl)phenyl)ethynyl)-1,2,4,5-tetramethylbenzene. Compounds of this type 
typically have a large singlet–triplet energy gap e.g. 1,4-bis(phenylethynyl)benzene (ET1 = 
2.56 eV, see supporting information). As a result, upon excitation of the metal complex 
intramolecular triplet-triplet energy transfer to and from the weakly coupled 4-((4-((4-(tert-
butyl)phenyl)ethynyl)phenyl)ethynyl)-1,2,4,5-tetramethylbenzene can occur which results in 
REET.25 
 
Table 1. Electrochemical data, emission wavelengths, photoluminescence quantum yields (PLQYs), and lifetimes for iridium complexes.  
 
Absorption, nm (ε, ×103 L 
mol-1 cm-1)a 
Emission (nm) PLQY 
(Φ)a 
Lifetime (τ), µs kr a 
×105 
s-1 
knr,a 
×105 
s-1 
Pure 
radiative 
lifetime 
(τ0)a, µs 
T1a 
(eV)  
Eox,a 
VFc/Fc+ solutiona filmb solutiona filmb 
Ir(ppy)2(acac)29  520 531 0.71 1.90 2.21 3.73 1.52 2.67 2.55 0.33 
Ir(Phppy)2(acac)23  560 521 0.96 1.20 1.16 8.00 0.33 1.25 2.34 0.34 
Ir(otolppy)2(acac)24  
261(6.78), 348(1.80), 
411(br), 463(br) 
547 522 0.52 0.93 1.76 5.59 5.16 1.79 2.51 0.34 
1 
262(5.35), 345(1.73), 
410(0.87) 
520 518 0.60 1.20 2.62 5.00 3.33 2.00 2.55 0.33 
2 
265(7.43), 363(2.21), 412 
(br) 
586  0.65 1.20  5.42 2.92 1.85 2.36 0.38 
3 
303(10.7), 362(3.96), 
470(br) 
597  0.57 1.00  5.70 4.30 1.75 2.35 0.34 
4 
283(8.98), 350(2.76), 
470(br) 
546  0.62 0.94  6.60 4.04 1.52 2.46 0.35 
5 
261(9.27), 343(1.97), 413 
(br), 465 (br), 487 (br) 
521  0.66 1.01  6.53 3.37 1.53 2.53 0.35 
6 
263(5.82), 315(7.27), 
366(3.74) 
585 553 0.54 0.98 1.21 5.51 4.69 1.81 2.33 0.36 
7 
296(9.05), 315(10.5), 
333(8.65), 371(6.59), 
376(6.38) 
611 557 0.38 0.69 1.41 5.51 8.99 1.82 2.27 0.38 
8 
263(5.82), 315(7.27), 
366(3.74) 
585 559 0.54 0.98 1.22 5.51 4.69 1.81 2.33 0.33 
9 270(5.91), 333(9.74) 603 c 0.28 0.92 c 3.04 7.83 3.29 2.31 0.33 
10 311(9.17), 352(3.91) 558 536 0.57 0.88 1.37 6.48 4.89 1.54 2.45 0.34 
11 331(16.1), 470(br) 574 543 0.50 1.35 1.17 3.70 3.70 2.70 2.45 0.35 
12 296(10.7), 313(9.13) 526 527 0.49 0.98 1.01 5.00 5.20 2.00 2.54 0.35 
13 333(16.9), 354(14.4) 524 535 0.49 13.5 2.23 0.36 0.38 27.5 2.53 0.35 
The radiative kr and non-radiative knr values in were calculated according to the equations:  
kr = Φ/τ and knr = (1 – Φ)/τ, from the quantum yields Φ and the lifetime τ values. aRecorded in DCM, recorded a in poly(butyl-co-isobutylmethacrylate) 
containing 0.1% wt film, c too insoluble to produce a homogenous film.
    
Figure 5. Emission spectra of iridium complexes recorded in dichloromethane (DCM), λex = 
410 nm: a) Ir(ppy)2(acac), complexes 2, 6, and 7; and b) complexes 7, 9, 11, and 13. 
 
OLED device fabrication and results 
OLED devices incorporating complexes Ir(Phppy)2(acac), Ir(otolppy)2(acac), 1, 6–8 and 10–
13 were fabricated, with the iridium complexes blended with poly(vinyl carbazole) (PVK) as 
a host material and 2-(4-tert-butylphenyl)-5-(4-biphenylyl)-1,3,4-oxadiazole (PBD) as an 
electron transport material to form a single, solution-processable (SP) emissive layer. Complex 
9 was not included as it was too insoluble for testing in SP devices, while the TIPS intermediate 
complexes 2–5 were not included. As an initial characterization of these complexes, in these 
simple SP devices the orientations of the emitting molecules were not aligned, and therefore 
the polarization characteristics of the electroluminescence emission were not investigated. 
 
Devices were fabricated in a nitrogen glove box environment on glass substrates coated with a 
150 nm pre-patterned layer of indium tin oxide (ITO). A 50 nm film of poly(3,4-
ethylenedioxythiophene) based dispersion (PEDOT, Clevios HIL 1.3) was deposited by spin 
coating, followed by spin coating of the 70 nm emissive layer from chlorobenzene solution 
blended in the ratio 100:40:8 PVK:PBD:Ir by weight. A 25 nm electron transporting layer of 
2,2′,2”-(1,3,5-benzinetriyl)-tris(1-phenyl-1-H-benzimidazole) (TPBI) and LiF/Al cathode 
were subsequently deposited by thermal evaporation. The overall structure of the OLED 
devices was ITO / PEDOT (50 nm) / PVK:PBD:Ir [100:40:8] (70 nm) / TPBI (25 nm) / LiF (1 
nm) / Al (100 nm). 
Normalised electroluminescence emission spectra of these OLED devices are shown in Figure 
6. 
 
Figure 6. Normalised electroluminescence emission of OLED devices incorporating 
Ir(Phppy)2(acac), Ir(otolppy)2(acac), 1, 6–8 and 10–13. 
 
The electroluminescent device emission spectra are similar to the photoluminescence emission 
for all complexes tested. As with the photoluminescence spectra, a red shift in 
electroluminescence is observed as the length of the emitter molecules increases. For example, 
the maximum emission wavelength of complexes with a o-tolyl spacer was redshifted from 
541 nm for Ir(otolppy)2(acac) to 559 nm for complex 11, while complexes with a duryl spacer 
showed a smaller redshift in emission from 526 nm for complex 1 to 533 nm for complex 13. 
Efficiency and luminance data for all OLED devices fabricated are summarized in Table 2, and 
full J-V-L and efficiency data are shown in Figure 7.  
Table 2. Summary of OLED device efficiency and luminance data. 
Complex 
EL,max 
 
(nm) 
Maximum 
luminance 
(cd/m2) 
EQE 
 
(%) 
Device 
efficiency 
(cd/A) 
Luminous 
efficacy 
(lm/W) 
EQE 
 
(%) 
Device 
efficiency 
(cd/A) 
Luminous 
efficacy 
(lm/W) 
CIEx,y 
At 100 cd/m2 At 1000 cd/m2 
Ir(Phppy)2(acac) 559 13150 4.7 14.8 7.2 6.3 22.0 7.7 (0.46, 0.54) 
Ir(otolppy)2(aca
c) 
541 11300 6.4 24.1 12.6 7.4 27.7 10.2 (0.39, 0.59) 
1 526 8995 6.1 24.4 12.8 6.9 26.2 10.3 (0.32, 0.64) 
6 583 2624 2.1 5.2 1.6 2.1 4.9 1.2 (0.55, 0.45) 
7 598 5025 5.3 10.7 4.2 4.7 9.3 2.7 (0.59, 0.40) 
8 577 1208 1.1 2.6 0.7 0.6 1.5 0.3 (0.52, 0.47) 
10 553 9629 5.8 18.9 9.1 6.2 21.6 7.9 (0.44, 0.55) 
11 559 7045 5.6 18.1 8.1 5.5 18.5 6.1 (0.45, 0.54) 
12 532 2957 1.7 5.9 1.9 1.6 5.9 1.5 (0.35, 0.62) 
13 533 2473 1.2 4.5 1.6 1.4 5.2 1.3 (0.36, 0.61) 
 
 
As well as the redshift in electroluminescence, the increased molecular length of the emitter 
molecules results, in general, in a decrease in the overall device efficiency and luminance, as 
well as an increase in the turn on voltage, Figure 7.  
 
For devices incorporating complexes with a otolyl spacer, for example, a reduction in 
efficiency was observed from 27.7 cd/A and 7.4% EQE (at a luminance of 1000 cd/m2) for 
Ir(otolppy)2(acac) to 18.5 cd/A and 5.5% EQE for complex 11. The complexes with a duryl 
spacer (1, 12, and 13) exhibited a greater reduction in device efficiency, from 26.2 cd/A and 
6.9% EQE for complex 1 to 5.2 cd/A and 1.4% EQE for complex 13. The exception was for 
the complexes with the alkyne directly attached to the pyridine, where the longer, redshifted 
complex 7 exhibited improved device performance, at 9.3 cd/A and 4.7% EQE, compared to 
complex 6 at 4.9 cd/A and 2.1% EQE. 
 
Turn on voltages required to attain a luminance of 1 cd/m2 ranged from around 4.5 V for the 
parent complexes Ir(otolppy)2(acac), Ir(Phppy)2(acac) and complex 1, up to 8 V for complex 
8. The higher turn on voltages correspond to increased trapping of electrons on the dopant 
complexes,30, 31 which may be attributed to the lower LUMO energies of the longer emitter 
molecules. The higher turn on voltages correspond in general to the complexes with lower 
LUMO energies, which may be attributed to an increase in the trapping of electrons by these 
complexes. With only small differences in the HOMO energies across the range of complexes, 
and therefore in the trapping of holes, the increase in trapping of electrons caused by the lower 
LUMO energy affects the balance of charge carriers in the device, reducing the current density 
and increasing the driving voltage.32, 33 Further optimisation of the device architecture for these 
complexes to improve the charge balance would lead to an improvement in driving voltage and 
device efficiency. 
 
These device results confirm the suitability of these linear complexes for use as dopant emitters 
for highly efficient solution-processable OLED devices, with the potential for alignment of the 
emitters in order to obtain polarized device emission. 
 Figure 7. OLED efficiency and J-V-L data for devices incorporating Ir(Phppy)2(acac), 
Ir(otolppy)2(acac), 1, 6–8 and 10–13. Device structure ITO / PEDOT (50 nm) / PVK:PBD:Ir 
[100:40:8] (70 nm) / TPBI (25 nm) / LiF (1 nm) / Al (100 nm). 
 
Linear Alignment  
As a cursory means of evaluating the effect of molecular alignment as a function of molecule 
length, PBiBM films containing 0.1% wt of the complexes were evaluated. The films were 
formed using a similar approach to that reported by Cunningham,34 whereby each film was 
drop-cast to yield a set of approximately 1 mm thick films. These films were then heated to 
60°C and stretched to twice their original length, after which they were cooled. This approach 
provided optically transparent films that could be stretched and that maintain elongation at 
room temperature. Film emission spectra were measured using a polarizing microscope (see 
supplementary information for details) to compare both the polarized emission spectra 
parallel and perpendicular of both the original and stretched films using equation 1, where PR 
= polarization ratio,  𝐼∥= the emission intensity of film parallel to the stretch direction, 𝐼⊥= the 
emission intensity of the film perpendicular to the stretch direction, and f is the correction 
factor to account for the internal polarization of the optical microscope (details of 
determination given in supporting information).35 
𝑃𝑅 =
𝐼∥−𝐼⊥𝑓
𝐼∥+𝐼⊥𝑓
 (Equation 1) 
Given the varied interactions of each of the complexes with the polymer, this technique 
reduced our ability to draw direct conclusions about individual complexes. When the 
polarization ratio was plotted against the end-to-end length of the all of the complexes, a 
general trend could be observed: each incremental increase in molecular length observed 
yielded a 7.1-fold increase in polarization, from Ir(ppy)2(acac) (11.6 Å) to complex 13 (49.2 
Å) (Figure 8). This result indicates that an increase in the emitters’ aspect ratios improves 
their ability to align mechanically.  
  
Figure 8. PR versus (vs.) complexes’ end-to-end length for stretched poly(butyl-co-isobutyl 
methacrylate) PBiBM films. 
 CONCLUSION  
A series of iridium complexes (1, and 6–13) with varied aspect ratios were synthesized 
through the use of TIPS-protected iridium synthons (complexes 2–5). By de-protecting these 
synthons in situ, it was possible to build complexes with lengths of up to 5 nm, a length 
difficult to achieve by traditional means. In addition, through the incorporation of a sterically 
induced ‘twist’ between the Ir(ppy)2(acac) core and the substituents, it was possible to control 
the degree of electronic coupling between the core and the substituents, allowing for 
independent controls over both photophysical and mechanical behaviors. Finally, through the 
use of mechanical alignment of complex-containing films, it was possible to demonstrate that 
increases in complex length improved emission alignment in stretched polymer films.  
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